Open AccessSixth report of adverse events with biological treatments in Argentina. BIOBADASAR registry report
Author(s) -
Gandhy Ponce Gómez,
Guillermo J. PonsEstel,
Gustavo Citera,
Emilie Soriano,
Verónica Saurit,
F. Benavidez,
E. Velozo,
David Dubinsky,
I. Exeni,
C. Gobi,
Gandhy Ponce Gómez,
Manuel Díaz,
Amelia Granel,
A. Smichowsky,
Gonzalo Garate,
Ana Quinteros,
E. Cavillon,
Ivan Petković,
María Silvia Larroudé,
M. de la Sota,
A Cappuccio,
G. Berbotto,
Agustina Alvarez,
Sílvia Papasidero,
Arlene Lazaro,
Marcos García,
M. Sacnún,
S. Soares de Souza,
A. Bertoli,
Victoria Bejarano,
Oscar Rillo,
E. Kerzberg,
R. Quintana,
Sonia M. Aguero,
Luisa Somma,
Vanesa Cruzat,
C. Battaglitti,
A. Perez Dávila,
M. Gallardo,
Daniela Figueiredo Corrêa Pereira,
M. Verando,
Sergio Paira,
Luc Martinez,
N. Aste,
Cecilia Pisoni,
Erika Catay,
César Graf,
Gustavo Casado,
Marı́a de la Vega
Publication year - 2019
Publication title -
revista argentina de reumatología
Language(s) - English
Resource type - Journals
eISSN - 2362-3675
pISSN - 0327-4411
DOI - 10.47196/rar.v30i1.461
Subject(s) - medicine , cohort , adverse effect , emergency medicine , family medicine
Objective: update the results of the BIOBADASAR registry on safety, duration and causes of treatment interruption after 8 years of follow-up. Methods: BIOBADASAR is a safety record of biological therapies established by the Argentine Society of Rheumatology. The description of BIOBADASAR 3.0 is presented, a cohort of 53 centers in Argentina followed prospectively from August 2010 to January 2018.